Stay updated on Pembrolizumab in Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:55:36.000Z thumbnail image
  3. Check
    28 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-02-17T18:59:20.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T15:50:12.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.2%
    Check dated 2025-02-03T10:52:12.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T02:03:54.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The intervention type has been updated to 'Verified 2022-12 by Denis Migliorini, University Hospital, Geneva' with a new status of 'Active, not recruiting' in revision v2.14.0, while the previous type of intervention was removed in revision v2.13.3.
    Difference
    0.6%
    Check dated 2025-01-12T22:42:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.